Your browser doesn't support javascript.
loading
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection.
Navarese, Eliano P; Podhajski, Przemyslaw; Gurbel, Paul A; Grzelakowska, Klaudyna; Ruscio, Eleonora; Tantry, Udaya; Magielski, Przemyslaw; Kubica, Aldona; Niezgoda, Piotr; Adamski, Piotr; Junik, Roman; Przybylski, Grzegorz; Pilaczynska-Cemel, Marta; Rupji, Manali; Specchia, Giuseppe; Pinkas, Jaroslaw; Gajda, Robert; Gorog, Diana A; Andreotti, Felicita; Kubica, Jacek.
Affiliation
  • Navarese EP; Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland; Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada; SIRIO MEDICINE Research Network, Bydgoszcz, Poland. Electronic add
  • Podhajski P; Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland; SIRIO MEDICINE Research Network, Bydgoszcz, Poland.
  • Gurbel PA; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA.
  • Grzelakowska K; Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland; SIRIO MEDICINE Research Network, Bydgoszcz, Poland.
  • Ruscio E; Dipartimento di Scienze Cardiovascolari, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Tantry U; Sinai Center for Thrombosis Research and Drug Development, Sinai Hospital of Baltimore, Lifebridge Health, Baltimore, Maryland, USA.
  • Magielski P; Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Kubica A; Department of Health Promotion, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Niezgoda P; Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Adamski P; Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland.
  • Junik R; Department of Endocrinology and Diabetology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Torun, Poland.
  • Przybylski G; Department of Lung Diseases, Neoplasms and Tuberculosis, Faculty of Medicine, Nicolaus Copernicus University, Torun, Poland.
  • Pilaczynska-Cemel M; Department of Lung Diseases, Neoplasms and Tuberculosis, Faculty of Medicine, Nicolaus Copernicus University, Torun, Poland.
  • Rupji M; Winship Cancer Institute of Emory University, Atlanta, Georgia, USA.
  • Specchia G; Department of Cardiology, Policlinico di Monza, Monza, Italy.
  • Pinkas J; Center of Postgraduate Medical Education, School of Public Health, Warsaw, Poland.
  • Gajda R; Gajda-Med Medical Center in Pultusk, Pultusk, Poland.
  • Gorog DA; School of Life and Medical Sciences, Postgraduate Medical School, University of Hertfordshire, Hertfordshire, United Kingdom; Faculty of Medicine, National Heart & Lung Institute, Imperial College, London, United Kingdom.
  • Andreotti F; Dipartimento di Scienze Cardiovascolari, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Direzione Scientifica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.
  • Kubica J; Interventional Cardiology and Cardiovascular Medicine Research, Department of Cardiology and Internal Medicine, Nicolaus Copernicus University, Bydgoszcz, Poland; SIRIO MEDICINE Research Network, Bydgoszcz, Poland.
J Am Coll Cardiol ; 81(3): 224-234, 2023 01 24.
Article in En | MEDLINE | ID: mdl-36653090

Full text: 1 Database: MEDLINE Main subject: Proprotein Convertase 9 / COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Proprotein Convertase 9 / COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Year: 2023 Type: Article